1021086

Novartis Pharma AG — FEI 3002807772

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 6, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Basel (Switzerland)